Gomez-Pinilla, Pedro J., Sara Morales, Cristina Camello-Almaraz, Rosario Moreno, María J. Pozo, and Pedro J. Camello signaling pathways induced by this gallbladder dysfunction. [Ca 2ϩ ]i was determined by epifluorescence microscopy in fura 2-loaded isolated gallbladder smooth muscle cells, and isometric tension was recorded from gallbladder muscle strips. F-actin content was quantified by confocal microscopy. Ca 2ϩ responses to the inositol trisphosphate (InsP 3 ) mobilizing agonist CCK and to caffeine, an activator of the ryanodine receptors, were impaired in cholecystitic cells. This impairment was not the result of a decrease in the size of the releasable pool. Inflammation also inhibited Ca 2ϩ influx through L-type Ca 2ϩ channels and capacitative Ca 2ϩ entry induced by depletion of intracellular Ca 2ϩ pools. In addition, the pharmacological phenotype of these channels was altered in cholecystitic cells. Inflammation impaired contractility further than Ca 2ϩ signal attenuation, which could be related to the decrease in F-actin that was detected in cholecystitic smooth muscle cells. These findings indicate that cholecystitis decreases both Ca 2ϩ release and Ca 2ϩ influx in gallbladder smooth muscle, but a loss in the sensitivity of the contractile machinery to Ca 2ϩ may also be responsible for the impairment in gallbladder contractility.
contractility; calcium stores; calcium channels; F-actin; calcium ion THE KEY EVENTS THAT MODULATE smooth muscle contraction include increases in the cytosolic Ca 2ϩ concentration ([Ca 2ϩ ] i ) and phosphorylation of the regulatory light chains of myosin II by myosin light chain kinase (32) . Changes in [Ca 2ϩ ] i are regulated through the control of Ca 2ϩ transport mechanisms across plasma and intracellular store membranes (4) . Because of the wide spectrum of Ca 2ϩ regulatory actions, alterations of [Ca 2ϩ ] i signals can have deep impact on cell function. Thus Ca 2ϩ deregulation has been reported to participate in conditions like cell death (21) or inflammation (42) . However, information regarding the nature of changes of [Ca 2ϩ ] i signals during inflammatory processes in smooth muscle is rather scarce. In gastrointestinal smooth muscle, there is evidence that inflammation attenuates Ca 2ϩ signals through changes in plasma membrane ion channel expression (11) and regulation (12) . By contrast, there are conflicting reports on the effects of inflammation on Ca 2ϩ release from intracellular stores (7, 26, 29) .
Acute inflammation in the absence of gallstones, a pathological condition commonly referred to as acute acalculous cholecystitis, is an increasingly prevalent complication among individuals in the intensive care unit and in patients without predisposing illness (2) . The pathogenesis of this disease is unclear. It has been speculated that impaired muscle contractility is secondary to inflammation and may play a role in the clinic pathology of acute acalculous cholecystitis (8, 23, 24) . Previous reports using functional methods have described that, in gallbladder smooth muscle, the main targets for inflammation are ion channels and G protein-coupled receptors of the plasma membrane, whereas intracellular pathways [inositol trisphosphate (InsP 3 ) receptors, protein kinase C, and G proteins] are not affected (43) . However, the effects of acute acalculous cholecystitis on gallbladder smooth muscle Ca 2ϩ signals have not been tested previously. The aim of this study was to explore the alterations of Ca 2ϩ signals during cholecystitis.
MATERIALS AND METHODS
Model of acute acalculous cholecystitis. Acute acalculous cholecystitis was induced in male guinea pigs by ligation of the common bile duct for 2 days. This method has been previously shown to reproduce the pathological changes seen in human acute acalculous cholecystitis (20, 23, 24, 43, 44) , and it was approved by the Ethical Committee of the University of Extremadura. A laparotomy was performed under anesthesia with ketamine hydrochloride (20 mg/kg ip) and xylacine (5 mg/kg ip). Next, the distal end of the common bile duct was ligated (4 -0 silk) at its junction with the duodenum using minimal manipulation of the bile duct and no manipulation of the gallbladder. Under these conditions, there was no interruption of the blood supply to the gallbladder. The surgical incision was then sutured. A group of control animals were sham operated, which included all the surgical steps except for the common bile duct ligation. After the operative procedures, the animals were housed separately, and they were provided with food and water ad libitum. Later (2 days), the animals were killed with deep halothane anesthesia and cervical dislocation for tissue harvest. Gallbladders were immediately placed in cold Krebs-Henseleit solution (K-HS; for composition, see Solutions and drugs) at pH 7.35. The gallbladder was opened from the end of the cystic duct to the base, and the mucosa was dissected away carefully.
Cell isolation. Gallbladder smooth muscle cells were dissociated enzymatically using a previously described method (25) . Briefly, after preparing the tissue as indicated above, the gallbladder was cut into small pieces and incubated for 34 min at 37°C in enzyme solution (ES, for composition, see Solutions and drugs) supplemented with 1 mg/ml BSA, 1 mg/ml papain, and 1 mg/ml dithioerythritol. Next, the tissue was transferred to fresh ES containing 1 mg/ml BSA, 1 mg/ml collagenase, and 100 M CaCl 2 and incubated for 9 min at 37°C. The tissue was then washed three times using ES, and the single smooth muscle cells were isolated by several passages of the tissue pieces through the tip of a fire-polished glass Pasteur pipette. The resultant cell suspension was kept in ES at 4°C until use, generally within 6 h. Cell viability was routinely checked by trypan blue staining of cells (85 Ϯ 5 and 83 Ϯ 7% of viability for control and cholecystitic cell suspensions, respectively). All experiments involving isolated cells were performed at room temperature (22°C).
Cell Contraction recording of guinea pig gallbladder strips. Gallbladder strips (measuring ϳ3 ϫ 10 mm) were mounted vertically in a 10-ml organ bath filled with K-HS maintained at 37°C and gassed with 95% O2-5% CO2. Isometric contractions were measured using force displacement transducers that were interfaced with a Macintosh computer using a MacLab hardware unit and software (ADInstruments, Colorado Spring, CO). The muscle strips were placed under an initial resting tension equivalent to 1.5 g load and allowed to equilibrate for 60 min, with solution changes every 20 min. Every strip coming from the same animal was used in a different experimental protocol. The direct effects of CCK, ionomycin, or KCl on gallbladder tone were studied by addition of these agents to the organ bath.
F-actin content measurement. The F-actin content of control and cholecystitic gallbladder smooth muscle cells was determined according to a previously published procedure (17) . Briefly, samples of cell suspensions (200 l) were placed in Na ϩ -HEPES solution and quickly transferred to 200 l ice-cold 3% (wt/vol) formaldehyde in PBS solution (for composition, see Solutions and drugs) for 10 min. Fixed cells were permeabilized by incubation for 10 min with 0.025% (vol/vol) Nonidet P-40 detergent dissolved in PBS. Cells were then incubated for 30 min with FITC-labeled phalloidin (FITC-phalloidin; 1 M) in PBS solution supplemented with 0.5% (wt/vol) BSA. After incubation, the cells were collected by centrifugation for 2 min at 10,000 g and resuspended in PBS solution. Staining of actin filaments was measured using a confocal laser-scanning system (model MRC-1024; Bio-Rad) with excitation wavelength of 488 nm and emission at 515 nm. The cellular F-actin content was quantified as arbitrary units of fluorescence using the ImageJ software.
Solutions and drugs. The K-HS contained (in mM): 113 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2 KH2PO4, 1.2 MgSO4, 25 NaHCO3, and 11.5 D-glucose. This solution had a final pH of 7.35 after equilibration with 95% O2-5% CO2. The ES used to disperse cells was made up of (in mM): 10 HEPES, 55 NaCl, 5.6 KCl, 80 sodium glutamate, 2 MgCl2, and 10 D-glucose, with pH adjusted to 7.3 with NaOH. The Na ϩ -HEPES solution contained (in mM): 10 HEPES, 140 NaCl, 4.7 KCl, 2 CaCl 2, 2 MgCl2, and 10 D-glucose, with pH adjusted to 7.3 with NaOH. The Ca 2ϩ -free Na ϩ -HEPES solution was prepared by substituting EGTA (1 mM) for CaCl2. The PBS solution used in F-actin studies contained (in mM): 137 NaCl, 2.7 KCl, 5.62 Na2HPO4, 1.09 NaH2PO4, and 1.47 KH2PO4, with pH adjusted to 7.2. Drug concentrations are expressed as final bath concentrations of active species. Drugs and chemicals were obtained from the following sources: (Ϯ)BAY K 8644, caffeine, CCK-(26 -33) sulfated, 1,4-dithio-DLthreitol, thapsigargin, FITC-phalloidin, nitrendipine, pinacidil, and trypan blue were from Sigma Chemical (St. Louis, MO); 2-aminoethoxydiphenylborane (2-APB) was from Tocris (Bristol, UK); 2,3,6-tri-O-butyryl-myo-inositol-1,4,5-trisphosphate-hexakis(propionoxymethyl)ester [Bt 3-Ins(1,4,5)P3-PM] was from SiChem (Bremen, Germany), fura 2-AM was from Molecular Probes (Molecular Probes Europe, Leiden, Netherlands); collagenase was from Fluka (Madrid, Spain); and papain was from Worthington Biochemical (Lakewood, NJ). Other chemicals used were of analytical grade from Panreac (Barcelona, Spain). Stock solutions of fura 2-AM, thapsigargin, ionomycin, pinacidil, and 2-APB were prepared in DMSO, and (Ϯ)BAY K 8644, nitrendipine, and FITC-phalloidin were prepared in ethanol. The solutions were diluted such that the final concentrations of DMSO or ethanol were Յ0.1% vol/vol. These concentrations of solvents did not interfere with fura 2 fluorescence.
Quantification and statistics. Results are expressed as means Ϯ SE of n cells or gallbladder strips. All results from [Ca 2ϩ ]i determinations are given as ⌬F340/F380. Gallbladder tension is given in millinewtons per milligram of tissue. Statistical differences between means were determined by Student's t-test. Differences were considered significant at P Ͻ 0.05.
RESULTS

To characterize Ca
2ϩ dynamics in cholecystitis, we challenged gallbladder smooth muscle cells with different types of stimuli: CCK, the natural agonist for gallbladder contraction, and caffeine, an activator of ryanodine receptors (RyR), were used to release Ca 2ϩ from intracellular stores, whereas KClrich medium and activation of capacitative (Fig. 1A) , which is entirely dependent on influx of extracellular Ca 2ϩ (15, 16) . As shown in Fig. 1A , cholecystitis decreased the initial peak by ϳ50% (control: 0.36 Ϯ 0.05 ⌬F 340 /F 380 , cholecystitis: 0.180 Ϯ 0.044 ⌬F 340 / F 380 , n ϭ 36 and 14 cells from 5 and 3 animals, respectively, P Ͻ 0.05). To more directly test whether Ca 2ϩ release through InsP 3 receptor was impaired by inflammation, we used 10 M Bt 3 -Ins(1,4,5)P 3 -PM, a membrane permeable analog of InsP 3 (27) , in a Ca 2ϩ -free medium, which caused a Ca Taken together, the results described above suggest that cholecystitis may reduce the Ca 2ϩ pool that is mobilized by InsP 3 and RyR agonists. This impairment could be because of a decrease in the Ca 2ϩ store content or a reduction in InsP 3 receptor and RyR sensitivity. To discriminate between these possibilities, we applied a low level of ionomycin in Ca 2ϩ -free solution, a treatment that releases the Ca 2ϩ stores while bypassing channels and receptors (18) . Figure 1D shows In addition to working via L-type Ca 2ϩ channels, we have recently demonstrated that capacitative Ca 2ϩ entry also mediates [Ca 2ϩ ] i signals in response to Ca 2ϩ mobilization from intracellular stores (15) , supporting the sustained phase of [Ca 2ϩ ] i signals in response to agonists in gallbladder smooth muscle cells. This mechanism is more complex in gallbladder smooth muscle than in other systems because depletion of stores initiates Ca 2ϩ influx through the following two pathways: voltage-independent "classical" capacitative Ca 2ϩ channels and coactivation of L-type Ca 2ϩ channels (15) . To activate this mechanism and test the effects of inflammation, we followed the protocol shown in Fig. 3A Fig. 3A ). In addition, the pharmacology of the remaining capacitative Ca 2ϩ entry was also altered in inflamed cells. Thus, although in normal cells capacitative Ca 2ϩ entry was sensitive to the well-recognized blocker of classical capacitative Ca 2ϩ channels [2-APB (100 M) and to nitrendipine (51 and 57% of reduction, respectively)], the residual capacitative Ca 2ϩ entry present in cholecystitic cells was insensitive to both of these compounds (0.069 Ϯ 0.012 ⌬F 340 /F 380 vs. 0.078 Ϯ 0.007 and 0.062 Ϯ 0.009 vs. 0.068 Ϯ 0.016 for nitrendipine and 2-APB, respectively, n ϭ 8 -11 cells from 3-6 animals; Fig. 3, B and C) . This was also the case when nitrendipine and 2-APB were applied together, a condition that almost blocked capacitative Ca 2ϩ entry in control cells (89% inhibition; Fig.  3D ). However, in cholecystitis, nitrendipine-and 2-APB-insensitive capacitative Ca 2ϩ entry was blocked by gadolinium (52% inhibition, 0.059 Ϯ 0.008 ⌬F 340 /F 380 vs. 0.031 Ϯ 0.007 ⌬F 340 /F 380 , n ϭ 10 cells from 3 animals, P Ͻ 0.05), a trivalent cation widely used to block capacitative channels in different cellular types, including excitable tissues (10, 31, 36) .
Taken together, our results show that both Ca 2ϩ release from the stores and Ca 2ϩ influx from extracellular medium are impaired by acute cholecystitis. Given that inflammation could alter fura 2 behavior because of changes in intracellular parameters (e.g., viscosity, pH,. . .), we compared the ratio of fura 2 fluorescence in response to a high level of ionomycin ( ] i is a major determinant of smooth muscle contraction; therefore, we investigated the effect of cholecystitis on gallbladder contractility to evaluate the association between impairment of [Ca 2ϩ ] i signals and contractile deficit in inflammation. Figure 5 , A-C, shows that, similar to [Ca 2ϩ ] i signals, the contraction induced by CCK, KCl, and capacitative Ca 2ϩ entry were also impaired, although to a greater extent than their corresponding Ca 2ϩ signals, which could indicate a decrease in the Ca 2ϩ sensitivity of contractile machinery. To check this, we assayed the contractile response to ionomycin since, as described above, inflammation did not change the ionomycininduced [Ca 2ϩ ] i signal. However, the same [Ca 2ϩ ] i elevation induced a much lower contraction in cholecystitic strips than in control tissue (control: 3.12 Ϯ 0.57 mN/mg, cholecystitis: 0.72 Ϯ 0.157 mN/mg, n ϭ 7 and 8 strips from 4 and 5 animals, respectively, P Ͻ 0.001; Fig. 5D ), which reveals that this disorder can also alter the contractile machinery independent of the Ca 2ϩ signal. To investigate one of the possible causes of this impairment in contractility, we determined the total amount of the contractile protein F-actin labeling gallbladder smooth muscle cells with FITC-stained phalloidin. We found that cholecystitis induced a statistically significant decrease in the actin content (control: 38.93 Ϯ 1.93, cholecystitis: 29.57 Ϯ 3.78, data as arbitrary units of fluorescence, n ϭ 16 and 13 cells from 5 and 3 animals, respectively, P Ͻ 0.05).
DISCUSSION
We present here data showing that acute acalculous cholecystitis evoked by bile duct ligation induces loss of Ca 2ϩ signals in response to physiological and pharmacological stimuli, involving a downregulation of Ca 2ϩ release and Ca 2ϩ entry mechanisms.
Bile duct ligation is a commonly used model of acute acalculous cholecystitis (23, 43) . This disease is accompanied by a loss of contractile response to agonists and intrinsic nerve stimulation and gallbladder stasis (23, 24) . Our results showing that cholecystitis impairs both contraction and [Ca 2ϩ ] i signals evoked by CCK and depolarization could explain, at least in part, this loss of contractility. The contractile impairment was detected not only in response to agonists and depolarization but also when the Ca 2ϩ increase was achieved by pharmacological release of intracellular Ca 2ϩ stores or by ionophore treatment.
However, the contractile impairment likely involves additional mechanisms, as evidenced by the decrease of a high-concentration ionomycin-evoked contraction. A possibility is that deregulation of Ca 2ϩ signals or some inflammatory mediators alter the expression of proteins involved in contraction, as suggested by the reduction in F-actin in cholecystitic cells.
Impairment of Ca 2ϩ signals during inflammation occurs at least at two levels: decrease of Ca 2ϩ release from pools and decrease of Ca 2ϩ influx through store-operated channels and voltage-operated L channels. In the case of stores, our data point to a decrease in RyR and/or InsP 3 receptor sensitivity to its agonists, since caffeine and the membrane permeable analog of InsP 3 , Bt 3 -Ins(1,4,5)P 3 -PM, released less Ca 2ϩ from intracellular stores in cholecystitic cells. Given the similar effects of a low concentrations of ionomycin in control and inflamed cells, a reduction in the Ca 2ϩ content of the stores cannot explain the impairment in Ca 2ϩ release. Because the assayed agonists act directly on the RyR and InsP 3 receptor and we measure directly the released Ca 2ϩ , alterations in the plasma membrane or G proteins could not be responsible for the reduced response to caffeine or to the membrane permeable analog of InsP 3 . It has been previously suggested that the muscle defect associated with acute inflammation in the gallbladder is located in the plasma membrane, with the signal transduction distal to the membrane receptors unaffected (43) . In that study, similar concentration-response curves were obtained when the contractile effect of InsP 3 was assayed in control and cholecystitic gallbladder smooth muscle cells, which could suggest that Ca 2ϩ release through InsP 3 receptors was totally preserved in inflammatory conditions. However, our study clearly demonstrates that the release of Ca 2ϩ through InsP 3 receptor stimulated by either CCK or Bt 3 -Ins(1,4,5)P 3 -PM is decreased in inflammation. Although the reduction in Bt 3 -Ins(1,4,5)P 3 -PM is only explained by alterations in the InsP 3 receptor, as discussed above, the impaired CCK-mediated [Ca 2ϩ ] i release could also reflect concurrent damage occurring at any place between receptor binding and Ca 2ϩ release mechanisms.
KCl-induced Ca 2ϩ influx in control gallbladder smooth muscle cells is sensitive to nitrendipine blockade, which means that KCl activates mainly L-type Ca 2ϩ channels in the gallbladder. The reduction in KCl-induced Ca 2ϩ transient by cholecystitis could be the result of the decrease in the L-type channel expression as described in inflamed circular smooth muscle of the canine colon (14) or by changes in the channel structure. However, the most striking feature of inflammationevoked Ca 2ϩ imbalance is the change of functional and pharmacological profiles of plasma membrane Ca 2ϩ entry pathways. Cholecystitis induced not only a loss of voltage-operated L-type Ca 2ϩ influx, as judged by the decrease of KCl-and BAY K 8644-induced [Ca 2ϩ ] i response, but also a change in the identity or at least the functional state of the channels activated, as evidenced by the insensitivity to nitrendipine. Two different classes of high-voltage-activated Ca 2ϩ channels can be distinguished pharmacologically: L-type Ca 2ϩ channels, which are highly sensitive to dihydropyridine agonists and antagonists, and non-L-type channels (P type, Q type, N type, and R type). The latter, which play a prominent role for fast neurotransmitter release in neurons, do not display dihydropyridine sensitivity but are selectively blocked by different peptide enzymes (5) . This difference in dihydropyridine sensitivity is the result of different ␣ 1 -subunit isoforms that, together with accessory subunits such as ␣ 2 , ␦, and ␤, form the Ca 2ϩ channel complexes. The isoforms ␣ 1S and ␣ 1C from Cav1.1 and Cav1.2 L-type channels (expressed in skeletal and cardiac/smooth muscles, respectively) present a dihydropyridine-binding domain that links with high affinity the dihydropyridine agonists and antagonists to promote or block current through the channels. The structural determinants of agonist and antagonist activity is the orientation of the pseudoaxial aryl group in the molecule. Enantiomers having an uporiented pseudoaxial aryl group are Ca 2ϩ channel blockers, whereas downorientation results in channel activation (agonists; for review, see Ref. 34) . In addition, individual amino acid residues that form the dihydropyridine pocket are required for agonist and antagonist activity (41) . The fact the BAY K 8644 was able to induce Ca 2ϩ influx in cholecystitic cells indicates that L-type Ca 2ϩ channels are still functional in inflammation, although they are activated by the dihydropyridine agonist to a less extent than in control cells (similar to KCl-induced Ca 2ϩ influx). The loss of antagonist sensitiveness could be explained by inflammation-mediated alterations in these specific amino acid residues that renders agonist activity. Another possible explanation for the lack of nitredipine effect is that, in inflammation, Cav1.2 L-type Ca 2ϩ channels change to the Cav1.3 subtype, which, being expressed in many of the cells that express Cav1.2, are less sensitive to dihydropyridine antagonists and require weak depolarization to activate (13) . This could explain that, in the presence of pinacidil, which counteracts the KCl-induced depolarization, we still observed KClmediated Ca 2ϩ influx in inflamed cells. However, it could also be possible that inflammation induced impairment in ATPdependent K ϩ channels and the consequent pinacidil-induced hyperpolarization. Thus, in the presence of pinacidil, KClinduced depolarization would be the same as in the presence of KCl. Changes in L-type channels can be of particular importance for contraction, given that these channels are not only essential for initiation of contraction in response to neurotransmitters as ACh, but they also participate in the maintenance of contraction once the stores have been depleted by CCK (15 (10, 31, 36) , it has also been described that this trivalent metal ion can block low-and high-voltage-activated Ca 2ϩ channels (3). This broad spectrum of blocking multiple channels isoforms could be responsible for the success of Gd 3ϩ on blocking capacitative Ca 2ϩ entry when the possible isoforms or the functional state of the channels is different under inflammatory stress.
Taken together, it is clear that desensitization of Ca 2ϩ pools and changes in the functional status of plasma membrane Ca 2ϩ channels account for the extensive loss of Ca 2ϩ signals and contraction observed in cholecystitis. However, it must be noted that the inflammation somehow alters contraction of cells independent of the [Ca 2ϩ ] i signal, as evidenced by the reduction of the contractile response to ionomycin. Here, we show for the first time that inflammation can alter the amount of contractile proteins such as actin, which could be responsible for the reduction in the sensitivity of the contractile machinery to Ca 2ϩ . This finding could, at least in part, explain the dramatic loss of contractile response compared with the impairment in Ca 2ϩ homeostasis. In agreement with our results, fluorescent staining for the actin cytoskeleton showed distortion and fragmentation in the intestinal epithelium and brush border of a murine dextran sodium sulfate-induced colitis model, which improved by antioxidant treatment (22) . It has been recently reported that the content of cytoskeletal protein markers specific for smooth muscle (including actin) was not modified in primary and secondary cultures grown from control and cholecystitic guinea pig gallbladders (19) . However, in that study, the analysis of cytoskeletal proteins was performed after at least 7-10 days (primary culture) or 10 -14 days (secondary culture) in culture media, an environment far from the in situ inflammatory conditions, which could reverse possible alterations caused by inflammation. In fact, we have previously described in guinea pig smooth muscle short-term changes in F-actin (7-8 min; see Ref. 17) .
Inflammation-induced alterations of other mechanisms that mediate Ca 2ϩ sensitization such as RhoA/Rho kinase pathwaymediated inhibition of myosin light-chain phosphatase (33) could also be responsible for the impairment in the contractile response.
During cholecystitis, gallbladder stasis can cause an increase in bile acid concentration that frequently precedes the onset of the inflammation (38) . Gallbladder smooth muscle cells are sensitive to hydrophobic bile acids, which increase in the pathogenesis of most acute cholecystitis cases (43, 44) . Because during bile duct ligation gallbladder smooth muscle cells are undoubtedly exposed to high concentrations of bile acids, proceeding from the lumen and from the vascular compartment, it is very likely that these acids can exert their deleterious effects on smooth muscle physiology (44) . In fact, recent reports have shown that hydrophobic bile acids can activate cationic conductances and Ca 2ϩ signals in pancreatic acinar cells (39, 40) . This could lead to a chronic state of depolarization, which can easily account for the genetic and functional changes observed in our experimental conditions. Additional studies are needed to determine the role of bile acids in gallbladder smooth muscle Ca 2ϩ homeostasis.
